Viewing Study NCT00908167

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:37 AM
Ignite Modification Date: 2026-04-16 @ 6:51 AM
Study NCT ID: NCT00908167
Status: COMPLETED
Last Update Posted: 2018-01-12
First Post: 2009-05-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies
Sponsor: St. Jude Children's Research Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia View
None Infantile Leukemia (Both AML and ALL) View
None Myelodysplastic Syndrome View
None Myelodysplastic/Myeloproliferative Neoplasms View
None Biphenotypic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None sorafenib View
None cytarabine View
None clofarabine View
None acute myeloid leukemia View
None acute promyelocytic leukemia View
None acute lymphoblastic leukemia View